Recently, we have identified a small molecule inhibitor of FOXM1 (Robert Costa Memorial Drug-1, RCM1) that has shown to be an effective anti-tumor agent and is also non-toxic in pre-clinical mouse models (19, 25). This evidence concerns the gene FOXM1 and neoplasm.